Ocunexus Therapeutics, Inc.
Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)
- Conditions
- Diabetic Foot Ulcers
- Interventions
- First Posted Date
- 2011-12-13
- Last Posted Date
- 2014-05-01
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 168
- Registration Number
- NCT01490879
- Locations
- 🇺🇸
Associated Foot and Ankle Specialists, LLC, Phoenix, Arizona, United States
🇺🇸University of Arizona Medical Center, Tucson, Arizona, United States
🇺🇸Center For Clinical Research Inc., Castro Valley, California, United States
A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers
- Conditions
- Venous Leg Ulcers
- Interventions
- First Posted Date
- 2010-09-13
- Last Posted Date
- 2014-05-01
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT01199588
- Locations
- 🇺🇸
Associated Foot and Ankle Specialists, LLC, Phoenix, Arizona, United States
🇺🇸Aung Foot Health Clinics, Tucson, Arizona, United States
🇺🇸Southern Arizona Limb Salvage Alliance, Tucson, Arizona, United States
A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects
- Conditions
- Persistent Epithelial Defect
- First Posted Date
- 2009-01-13
- Last Posted Date
- 2010-02-26
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT00821561
The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers
- Conditions
- Diabetic Foot Ulcer
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2010-08-31
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00820703
- Locations
- 🇳🇿
Middlemore Hospital, Auckland, New Zealand
A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study)
- Conditions
- Venous Ulcer
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2012-09-18
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 98
- Registration Number
- NCT00820196
- Locations
- 🇺🇸
Centre for Clinical Research, San Francisco, California, United States
🇺🇸Pacific Wound Center, Stockton, California, United States
🇺🇸Penn North Centers for Advanced Wound Care, Erie, Pennsylvania, United States
- Prev
- 1
- 2
- Next